Monday, May 09, 2016 11:39:23 AM
Furthermore, T. Ichim speaks about his research on the BORIS method of killing cancer cells which MolecuVax is based on (I thought T. Ichim's BORIS IP belonged to RGBP? Is MolecuVax based on T. Ichim's IP bought by RGBP, but changed slightly, or is this being done in MX because the patent is only valid in US? I have no idea, but this musical chairs of scientists and Board Members and now President being CEO of another competing company simultaneously just doesn't look good for us.
check this link MolecuVax trials
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM